INmune Bio, Inc. (INMB)
NASDAQ·Healthcare·Biotechnology
$1.53
+0.33%
Mkt Cap $43.07M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$22.00
Range $22.00 – $22.00
Implied Upside
+1342.6%
Consensus $22.00 vs current $1.53
NASDAQ·Healthcare·Biotechnology
$1.53
+0.33%
Mkt Cap $43.07M
No recent rating data.
Price Target (1 analysts)
$22.00
Range $22.00 – $22.00
+1342.6%
Consensus $22.00 vs current $1.53